CAS: 593960-11-3; N-(5-(4-Chloro-3-(N-(2-Hydroxyethyl)Sulfamoyl)Phenyl)-4-Methylthiazol-2-yl)Acetamide

主要参考文献

1. Inhibitors of the PI3k/Akt/Ikk/NF-kb signalling pathway, pharmaceutically acceptable salts thereof and compositions containing said inhibitors for prophylaxis and treatment of viral diseases. By Fedichev, Petr Olegovich; Vinnik, Andrey Alexandrovich. From PCT Int. Appl. (2013), WO 2013147649 A2 20131003, 2. Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo. By Spickler, Catherine; Lippens, Julie; Laberge, Marie-Kristine; Desmeules, Sophie; Bellavance, Edith; Garneau, Michel; Guo, Tim; Hucke, Oliver; Leyssen, Pieter; Neyts, Johan; et al. From Antimicrobial Agents and Chemotherapy (2013), 57(7), 3358-3368. , 3. Autoimmune and inflammatory disorder therapy using inhibitors of phosphatidylinositol-4-kinase IIIβ and screening methods thereof By Herman, Jean; Louat, Thierry; Huang, Qiuya; Vanderhoydonck, Bart; Waer, Mark; Herdewijn, Piet From PCT Int. Appl. (2013), WO 2013034738 A1 20130314, 4. Methods for predicting cancer treatment responsiveness to phosphatidylinositol 3-kinase (PI3K) inhibitors. By Jane, Stephen M.; Darido, Charbel. From PCT Int. Appl. (2013), WO 2013029116 A1 20130307, 5. Coxsackievirus mutants that can bypass host factor PI4KIIIβ and the need for high levels of PI4P lipids for replication. By van der Schaar, Hilde M.; van der Linden, Lonneke; Lanke, Kjerstin H. W.; Strating, Jeroen R. P. M.; Puerstinger, Gerhard; de Vries, Erik; de Haan, Cornelis A. M.; Neyts, Johan; van Kuppeveld, Frank J. M. From Cell Research (2012), 22(11), 1576-1592. , DOI:10.1038/cr.2012.129 6. Methods for treating oncovirus positive cancers. By Jimeno, Antonio; Hausman, Diana F.; Peterson, Scott. From PCT Int. Appl. (2012), WO 2012118978 A1 20120907, 7. Methods and compositions targeting signaling pathways for the treatment of cancer By Brugge, Joan S.; Muranen, Taru; Mills, Gordon; Selfors, Laura. From PCT Int. Appl. (2011), WO 2011133668 A2 20111027, 8. Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity By Arita, Minetaro; Kojima, Hirotatsu; Nagano, Tetsuo; Okabe, Takayoshi; Wakita, Takaji; Shimizu, Hiroyuki. From Journal of Virology (2011), 85(5), 2364-2372. , DOI:10.1128/JVI.02249-10 9. Modification of proteins for detection in cellular assays By Treiber, Daniel Kelly; Lewis, Warren G.; Wodicka, Lisa M. From PCT Int. Appl. (2010), WO 2010124157 A1 20101028, 10. Shaping Development of Autophagy Inhibitors with the Structure of the Lipid Kinase Vps34 By Miller, Simon; Tavshanjian, Brandon; Oleksy, Arkadiusz; Perisic, Olga; Houseman, Benjamin T.; Shokat, Kevan M.; Williams, Roger L. From Science (Washington, DC, United States) (2010), 327(5973), 1638-1642. , 11. Discovery of drug-resistant and drug-sensitizing mutations in the oncogenic PI3K isoform p110α By Zunder, Eli R.; Knight, Zachary A.; Houseman, Benjamin T.; Apsel, Beth; Shokat, Kevan M. From Cancer Cell (2008), 14(2), 180-192. , DOI:10.1016/j.ccr.2008.06.014 12. Phosphoinositide modulation for the treatment of neurodegenerative diseases By Kim, Tae-Wan; Dipaolo, Gilbert; Kang, Min Suk; Berman, Diego; McIntire, Laura Beth Johnson From PCT Int. Appl. (2008), WO 2008064244 A2 20080529, 13. Design of Drug-Resistant Alleles of Type-III Phosphatidylinositol 4-Kinases Using Mutagenesis and Molecular Modeling By Balla, Andras; Tuymetova, Galina; Toth, Balazs; Szentpetery, Zsofia; Zhao, Xiaohang; Knight, Zachary A.; Shokat, Kevan; Steinbach, Peter J.; Balla, Tamas From Biochemistry (2008), 47(6), 1599-1607. , DOI:10.1021/bi7017927 14. A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling By Knight, Zachary A.; Gonzalez, Beatriz; Feldman, Morri E.; Zunder, Eli R.; Goldenberg, David D.; Williams, Olusegun; Loewith, Robbie; Stokoe, David; Balla, Andras; Toth, Balazs; et al From Cell (Cambridge, MA, United States) (2006), 125(4), 733-747. , 15. A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma . By Fan, Qi-Wen; Knight, Zachary A.; Goldenberg, David D.; Yu, Wei; Mostov, Keith E.; Stokoe, David; Shokat, Kevan M.; Weiss, William A. From Cancer Cell (2006), 9(5), 341-349. 16. 5-Phenylthiazole derivatives and their use as phosphatidylinositol 3-kinase (Pi3K) inhibitors for the treatment of allergic and inflammatory diseases. By Bruce, Ian; Finan, Peter; Leblanc, Catherine; McCarthy, Clive; Whitehead, Lewis; Blair, Nicola Elaine; Bloomfield, Graham Charles; Hayler, Judy; Kirman, Louise; Oza, Mrinalini Sachin; et al. From PCT Int. Appl. (2003), WO 2003072557 A1 20030904,

合成参考文献

摘要:S55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749